We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$65.9B
AUM Growth
+$1.18B
Cap. Flow
-$1.31B
Cap. Flow %
-1.98%
Top 10 Hldgs %
22.04%
Holding
1,682
New
170
Increased
573
Reduced
627
Closed
177

Sector Composition

Rank Sector Weight
1 Financials 20.43%
2 Technology 19.05%
3 Industrials 12.77%
4 Healthcare 9.77%
5 Energy 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
1476
Rigel Pharmaceuticals
RIGL
$681M
$38.1K ﹤0.01%
2,910
DHC
1477
Diversified Healthcare Trust
DHC
$2.15B
$36.1K ﹤0.01%
15,549
RSI icon
1478
Rush Street Interactive
RSI
$2.77B
$35.4K ﹤0.01%
+11,099
New +$34.3K
LYEL icon
1479
Lyell Immunopharma
LYEL
$317M
$34.7K ﹤0.01%
560
CCO icon
1480
Clear Channel Outdoor Holdings
CCO
$1.23B
$33.1K ﹤0.01%
22,230
PL icon
1481
Planet Labs
PL
$7.3B
$32.8K ﹤0.01%
10,119
SHCR
1482
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$32.8K ﹤0.01%
18,951
PSTX
1483
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$32.6K ﹤0.01%
+18,832
New +$48.1K
CLSD
1484
DELISTED
Clearside Biomedical
CLSD
$32.4K ﹤0.01%
1,911
DM
1485
DELISTED
Desktop Metal, Inc.
DM
$31.7K ﹤0.01%
1,814
+440
+32% +$8.82K
AMWL icon
1486
American Well
AMWL
$180M
$31.6K ﹤0.01%
752
RNAC icon
1487
Cartesian Therapeutics
RNAC
$229M
$31K ﹤0.01%
923
+393
+74% +$14.1K
CERS icon
1488
Cerus
CERS
$433M
$27.8K ﹤0.01%
11,361
FUBO icon
1489
FuboTV Inc
FUBO
$261M
$26K ﹤0.01%
963
CDTX
1490
DELISTED
Cidara Therapeutics
CDTX
$25.5K ﹤0.01%
+1,128
New +$26.5K
SPRO icon
1491
Spero Therapeutics
SPRO
$67.7M
$25.3K ﹤0.01%
+17,198
New +$29.4K
AKBA icon
1492
Akebia Therapeutics
AKBA
$354M
$24.5K ﹤0.01%
27,199
-14,216
-34% -$13.7K
SLGC
1493
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$23.1K ﹤0.01%
10,200
GEVO icon
1494
Gevo
GEVO
$360M
$20.2K ﹤0.01%
+13,034
New +$16.8K
ME
1495
DELISTED
23andMe Holding Co
ME
$19.9K ﹤0.01%
589
MVST icon
1496
Microvast
MVST
$269M
$18.4K ﹤0.01%
10,990
NVTA
1497
DELISTED
Invitae Corporation
NVTA
$18K ﹤0.01%
15,402
PTRA
1498
DELISTED
Proterra Inc. Common Stock
PTRA
$17.6K ﹤0.01%
14,414
+500
+4% +$614
AMRS
1499
DELISTED
Amyris Inc.
AMRS
$15.4K ﹤0.01%
13,145
BHIL
1500
DELISTED
Benson Hill, Inc.
BHIL
$14.8K ﹤0.01%
334

Similar funds

Mackenzie Financial's Q2 2023 Portfolio in Review

As of Q2 2023, Mackenzie Financial held 1,682 positions worth $65.9B, up 1.8% from $64.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mackenzie Financial's Q2 2023 filing shows 170 new, 573 increased, 627 reduced and 177 closed positions. Its largest new stake was Brookfield Infrastructure Partners: 4,946,361 shares worth $181M. The largest sale was Jacobs Solutions, an estimated $359M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Mackenzie Financial's largest Q2 2023 buy was Brookfield Infrastructure Partners: 4,946,361 shares worth $181M.
  • Mackenzie Financial added most to CAE Inc. Common Shares in Q2 2023, an estimated $163M increase.
  • Mackenzie Financial's biggest Q2 2023 reduction was Jacobs Solutions, cutting an estimated $359M.
  • Mackenzie Financial fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $99.8M.
  • Mackenzie Financial's ten largest holdings make up 22% of its $65.9B portfolio in Q2 2023.
  • Mackenzie Financial opened 170 new positions and closed 177 in Q2 2023.
  • Mackenzie Financial's portfolio value rose 1.8% quarter-over-quarter to $65.9B.

Based on Mackenzie Financial's 13F filing for Q2 2023, filed 3 Aug 2023.